The risk for de-novo HCC was comparable between carriers and non-carriers of the PNPLA3 rs738409 G-allele (aHR: 1.446, 95%CI: 0.600–3.484, p = 0.411; Figure 2). Here, PNPLA3 is linked to hepatocellular carcinoma.